Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.370
-0.030 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed
Annovis Bio Employees
As of December 31, 2023, Annovis Bio had 16 total employees, including 6 full-time and 10 part-time employees. The number of employees increased by 11 or 220.00% compared to the previous year.
Employees
16
Change (1Y)
11
Growth (1Y)
220.00%
Revenue / Employee
n/a
Profits / Employee
-$2,558,694
Market Cap
60.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Apyx Medical | 252 |
| WORK Medical Technology Group LTD | 216 |
| Vor Biopharma | 168 |
| DBV Technologies | 105 |
| BeyondSpring | 36 |
| Milestone Scientific | 17 |
| Immix Biopharma | 17 |
ANVS News
- 16 days ago - Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today's Marketplace - GlobeNewsWire
- 17 days ago - /C O R R E C T I O N -- Today's Marketplace/ - PRNewsWire
- 26 days ago - Annovis to Host Year-End Investor Webcast on December 11, 2024 - GlobeNewsWire
- 7 weeks ago - IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio - GlobeNewsWire
- 2 months ago - FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs - GlobeNewsWire
- 2 months ago - Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases - GlobeNewsWire
- 2 months ago - Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations - GlobeNewsWire
- 3 months ago - Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire